Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
For me, the position we now find the company in, is that we have two tests effectively ready for market, validation and optimisation are in progress or virtually completed. The progress now is with finalising the right manufactures and production capacities with the right costs. They may even be ahead of this. But, if both the BAMS and POC LFT are as good and simple as they should be. Then when they announce to the world global orders should come flying in and the quantities will be vast. So I expect the business to be getting everything ready before making the huge announcement to the market.
I am extremely confident that we will see two very significant announcements very soon. They will be a catalyst to a rapid growth of opportunities for Avacta in the world of diagnostics. But more importantly they will help accelerate the growth of the business in the therapeutics business which will get a very significant global opportunity and publicity.
Viruses and cancer are not going away and Avacta has the ability to make a huge difference and contribution to the fight and Affimer technology will be a major success.
In the meantime small percentage buys and sells at strategic opportunities are helping my portfolio of Avacta shares grow day by day.
But one of theses days Avacta will put out an RNS during the day and we will rocket!
I am keeping the faith and patience will be rewarded.
Have a good day all! I agree with Ophidian a blue day!
Cheers Rich.
maybe the reason they raised some money was so they could expand under own steam, and get things in place prior to having test design finished.
Told you its a down day today, it'll continue like this till news
Just listening to BBC Radio 4 inside health which referred to the tests the Government went for this week but then tantalisingly referred to a new test in trials that can be done at the bedside and is much faster than 90 mins and is very accurate. The researcher did say the trial results were out soon but under imbargo as they are working with a manufacturer and the info is sensitive. Could it be Avacta? Have a listen see what you think..
Captain - looking at the literature Affimers can be produced at around 100mg/l of bacterial culture. Let’s say around 10 to 100ng is striped on the strip. This means between a million and ten million per 1L batch. I can easily produce 10-20L of bacterial culture in my lab per evening so yes Avacta can produce enough.
Ok - did anyone else just read what Nostra said?
Price would've shot up if it was AVCT
Ah - don't think it is a avacta. Sounds like a cassette type test - guessing it is LAMP.
Whoever holds the licence to that test is on to a winner, the doctor in charge is super positive about how accurate it is, but under embargo obviously
Yep, Radio4 Inside Health, not really enough info to determine if AVCT. Not clear if Antigen or Antibody, and no details on equipment etc. Given AVCT likely disposable consumer device or Mass Spec it seemed unlikely to be ours? To be honest pretty poor report in terms of detail.
GLA
ha ha I'm a blagger and everyday the price is falling, I think AVCT are the ones blagging as they haven't got the test ready.
I actually think it’s us !
Global, just for fun, are you in or out currently?
I'm out waiting for £1.10-1.20 to arrive
Thank you, Global. Appreciate your honesty. Gonna be a sore one for you if the BIG RNS lands in the morning though, isn’t it? Dangerous game :-)
I still have some in there but will wait for the drop as don't see it happening with the news this week although could he all wrong
Think it is Optigene
I LIKE SARDINES, DO YOU ?
Jimmy boy calm down, I'm responding to EricHorseman
It’s NCYT’s Exsig- direct 60 min test
Personally, I love Global's fantastic and insightful posts. If we all followed his strategies, we'd be millionaires...in Narnia or Cloud Cuckoo Land. Captain Obvious is getting concerned for his job.
Like i said if it was AVCT it would've shot up and looks like its NCYT, they've shot up in the last 30mins. Guys don't get too emotionally attached with AVCT its let people down with timelines so expect the unexpected
One day purple lackey is going to post something useful. The answer is yes if you are a taker.
Must be love
Being it was Southampton, a 60 minute test and was a development of an existing lab test, probably rules out AVCT.
The full interview can be heard at:
https://www.bbc.co.uk/sounds/play/m000lg48